Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (APPLE)
This study has been completed.
Study NCT01220050
Information provided by Mario Negri Institute for Pharmacological Research
First Received on October 11, 2010.
Last Updated on February 21, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
